paclitaxel has been researched along with Neoplasms, Squamous Cell in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bettocchi, S; Cicinelli, E; Cormio, G; Crupano, FM; Del Vecchio, V; Fumarulo, VV; Loizzi, V; Minicucci, V; Resta, L; Vimercati, A | 1 |
| Dahlberg, SE; Hoang, T; Johnson, DH; Schiller, JH | 1 |
| Dakhil, SR; Hirsh, V; Hon, JK; Okamoto, I; Orsini, J; Page, RD; Renschler, MF; Socinski, MA; Yamamoto, N; Zhang, H | 1 |
| Gruensfelder, P; Hagen, R; Polednik, C; Roller, J; Schmidt, M | 1 |
| Allen, AM; Annino, DJ; Busse, PM; Chan, AW; Clark, JR; Goguen, LA; Haddad, RI; Li, Y; Norris, CM; Posner, MR; Tishler, RB; Wirth, LJ | 1 |
| Fang, Q; Li, P; Ou, W; Sun, HB; Wang, SY; Yang, H; Ye, X; Zhang, BB | 1 |
| Fujita, K; Ishiguro, Y; Kimura, M; Kondo, N; Matsuda, H; Sakakibara, A; Takahashi, H; Tsukuda, M | 1 |
| Blumenschein, G; Boatright, DH; Brandon Gunn, G; El-Naggar, AK; Kies, MS; Lewin, JS; Li, G; Steinhaus, GD; Sturgis, EM | 1 |
| Birnbaum, A; Dipetrillo, T; Follett, N; Joyce, D; Khurshid, H; Luppe, D; Merriam, P; Puthawala, Y; Rathore, R; Safran, H; Sio, TT; Thomas, A; Wanebo, H | 1 |
| Glisson, BS | 1 |
| Belda-Iniesta, C; Casado, E; Cejas, P; de Castro, J; Feliu, J; Fresno Vara, JA; González-Barón, M; Hardisson, D; Nistal, M; Ordóñez, A; Sánchez, JJ | 1 |
| Akino, K; Hiratsuka, H; Imai, K; Kashima, L; Mita, H; Nishikawa, N; Noguchi, M; Ogi, K; Sasaki, Y; Satoh, A; Shinomura, Y; Suzuki, H; Tokino, T; Toyota, M | 1 |
| Balestrino, M; Fei, F; Gabriele, A; Lissoni, A; Mangioni, C; Parma, G; Zanetta, G | 1 |
1 review(s) available for paclitaxel and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
The role of docetaxel in the management of squamous cell cancer of the head and neck.
Topics: Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Docetaxel; Head and Neck Neoplasms; Humans; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Paclitaxel; Radiation-Sensitizing Agents; Taxoids | 2002 |
8 trial(s) available for paclitaxel and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Squamous Cell; Paclitaxel; Retrospective Studies; Taxoids; Treatment Outcome | 2013 |
Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Squamous Cell; Organoplatinum Compounds; Paclitaxel; Survival; Survival Rate; Treatment Outcome | 2013 |
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease Progression; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms, Squamous Cell; Paclitaxel; Panitumumab; Patient Compliance; Radiotherapy, Intensity-Modulated; Treatment Outcome | 2010 |
Adjuvant carboplatin-based chemotherapy in resected stage IIIA-N2 non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Paclitaxel; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2010 |
Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Female; Follow-Up Studies; Glossectomy; Humans; Ifosfamide; Induction Chemotherapy; Male; Middle Aged; Neck Dissection; Neoplasms, Squamous Cell; Paclitaxel; Prognosis; Survival Analysis; Tongue Neoplasms; Treatment Outcome; Young Adult | 2012 |
Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a survival analysis of a Brown University Oncology Group phase II study.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Chemoradiotherapy; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Paclitaxel; Survival Analysis; Treatment Outcome | 2014 |
New insights in beta-tubulin sequence analysis in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; DNA, Neoplasm; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Squamous Cell; Paclitaxel; Tubulin | 2003 |
Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Paclitaxel; Remission Induction; Salvage Therapy; Survival Analysis; Survival Rate; Uterine Cervical Neoplasms | 1999 |
4 other study(ies) available for paclitaxel and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
A phase II study: dose-dense carboplatin and paclitaxel as neoadjuvant chemotherapy in locally advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carboplatin; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasms, Squamous Cell; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms | 2018 |
The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Fluorescent Antibody Technique; Humans; Keratinocytes; Laryngeal Neoplasms; Neoplasms, Squamous Cell; Paclitaxel; Tubulin | 2009 |
Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines.
Topics: Adenoviridae Infections; Adenovirus E1A Proteins; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bacterial Proteins; Carcinoma; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, myc; Head and Neck Neoplasms; Humans; Neoplasms, Squamous Cell; Oncolytic Virotherapy; Oncolytic Viruses; Paclitaxel; Receptors, Virus; RNA, Messenger; S Phase; Squamous Cell Carcinoma of Head and Neck; Streptolysins; Telomerase | 2011 |
Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Proteins; Cell Division; Docetaxel; Drug Resistance, Neoplasm; Female; G2 Phase; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Microtubules; Middle Aged; Mouth Neoplasms; Neoplasm Proteins; Neoplasms, Squamous Cell; Paclitaxel; Poly-ADP-Ribose Binding Proteins; RNA, Small Interfering; Taxoids; Ubiquitin-Protein Ligases | 2005 |